Aveanna Healthcare Upgraded to Buy on Improved Profitability and Strong EBITDA Outlook

Key Facts

1Aveanna Healthcare Holdings (AVAH) was upgraded to a 'Buy' rating due to improved profitability and resilient demand for home healthcare services.

2Adjusted EPS for Q4 2025 was $0.17, supported by one-time tax benefits and merger costs.

3FY 2026 revenue guidance was disappointing at $2.54–$2.56 billion, while adjusted EBITDA guidance slightly exceeded consensus estimates.

Aveanna Healthcare Holdings (AVAH) has received a rating upgrade to 'Buy' following its fourth-quarter 2025 earnings report. The upgrade is primarily driven by the company's improved operational efficiency and resilient demand within the home healthcare sector. For Q4 2025, the company reported an adjusted EPS of $0.17, bolstered by one-time tax benefits and merger-related costs. While the revenue guidance for fiscal year 2026 of $2.54–$2.56 billion fell short of expectations, the adjusted EBITDA outlook exceeded consensus estimates. This positive EBITDA guidance suggests a strong focus on profitability and margin expansion despite the revenue headwinds. Analysts believe that the company's ability to manage costs effectively positions it well for future growth in a competitive market.

Create Free Account

Sources: